Challenges and strategies for adoption of biologicals

Rhinology Future Debates Brussels 2018

Prof. dr. Claus Bachert shares strategies for the adoption of biological treatment for patients with CRSwNP and integrated care pathways for CRS. And also explain possibilities for treatment and definition of patients who should be treated with monoclonal antibodies.

Panellists

Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Patient representatives.